| MillSO Changsha Allso E-Commerce Co., LTD
2364695 27 Nov 2024 | on 27 Nov 2024 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Audio cables; headphones; loudspeakers; portable speakers; rechargeable batteries for electric vehicles; rechargeable batteries for mobile phones; remote controls for stereos; smart home hubs; smart speakers; USB cables; wires, electric | | | FEELSO Shenzhen Longtengxiang Technology Co., Ltd.
2356538 17 Oct 2024 | on 17 Oct 2024 | Class 011 Class 011 Environmental Control Instrument Products (lighting,heating,cooling,cooking) Atomizing shower nozzles; bath fittings; bath installations; faucet filters; faucets; faucets for pipes and pipelines; hand-held showers; hot tub jets; kitchen sinks, kitchen faucets, sink strainers with baskets, sink grids; mixer faucets for water pipes; shower heads; showers; single-lever faucets for sinks; taps for wash-hand basins; water filtering units for domestic use; water purifiers for industrial purposes | | | RILSO XIANG LU
2312683 28 Feb 2024 | on 28 Feb 2024 | Class 028 Class 028 Toys and Sporting Goods Products Baby toys; bath toys; beach toys; children's multiple activity toys; construction toys; dolls, doll clothing, and doll accessories; drawing toys; educational toys; Halloween play sets; inflatable ride-on pool toys; kids gardening tool sets; kitchen playsets; model toys; music box toys; outdoor activity play sets; parlor games; party games; play tents; toy blocks; toy tea sets | | | ALLSO AWUSEM COSMETICS LIMITED
2301193 22 Dec 2023 | on 22 Dec 2023 | Class 003 Class 003 Cosmetics and Cleaning Products Beauty masks; cosmetic creams; cosmetic pencils; cosmetics; eyebrow pencils; incense; lip glosses; lipsticks; lotions for cosmetic purposes; make-up; make-up palettes containing cosmetics; make-up powder; mascara; micellar water; nail varnish; perfumery; pomades for cosmetic purposes; sheet masks for cosmetic purposes; toners for cosmetic use | | | ALSO LES PRODUCTIONS ALSO INC.
2296198 30 Nov 2023 | on 30 Nov 2023 | Class 041 Class 041 Education and Entertainment Services Développement, création, production, distribution et postproduction d'émissions de télévision, de films, de documentaires, de courts métrages. | | | La SALSO Sophianne Fortin
2277636 27 Aug 2023 | on 27 Nov 2024 | Class 041 Class 041 Education and Entertainment Services Présentation de spectacles musicaux; services de divertissement sous forme de spectacles de variétés musicales; services de divertissement sous forme de spectacles musicaux en direct | | | YRIKLSO SHENZHEN JINGXI TECHNOLOGY CO. LTD.
2264899 20 Jun 2023 | on 30 Oct 2024 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Audio equipment for vehicles, namely, loud speakers for automotive audio systems; audio speakers; batteries and battery chargers for mobile telephones; cell phone battery chargers for use in vehicles; computer keyboards; computer mouse; covers for smartphones; ear phones; laptop computers; personal stereos; protective covers for smartphones; protective films adapted for smartphone screens; smartphone mounts; USB cables; wireless charging pads for smartphones | | | NUJILSO GLAXO GROUP LIMITED
2238725 04 Jan 2023 | on 09 Sep 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, pulmonary, cardiorenal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the treatment of blood diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle cell disease, anaemia, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, ligament injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin infections namely acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of irritable bowel disorders and symptoms, digestive disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrhea and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids and leiomyoma; pharmaceutical preparations and substances for use in urology, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, cholestatic pruritus and primary biliary cholangitis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and psychoses; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines for human use; pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of nephrological related diseases and disorders. | | | LUNVELSO ABBVIE INC.
2215583 13 Oct 2022 | on 13 Oct 2022 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical substances and preparations for the treatment of oncological diseases and disorders | | | LETCELSO GLAXO GROUP LIMITED
2189385 14 Apr 2022 | on 12 Jan 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely autoimmune diseases and disorders; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders, namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders, namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment, namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders, namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely dermatitis, skin and skin structure infections, namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders, namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders, namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction, namely erectile dysfunction, male and female sexual dysfunction disorders, namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders, namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations, namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders, namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases, namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue, namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines, namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders, namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy. | |